Final answer:
Teriparatide is the medication that does not inhibit bone reabsorption; instead, it enhances the formation activity of osteoblasts. Alendronate, Risedronate, and Calcitonin are used to maintain bone density by inhibiting osteoclast activity.
Step-by-step explanation:
All of the following medications can be prescribed to inhibit bone reabsorption except Teriparatide (D). Medications like Alendronate (A), Risedronate (B), and Calcitonin (C) are used to slow down the breakdown of bone by inhibiting osteoclast activity, which helps maintain bone density and minimizes the risk of fractures. In contrast, Teriparatide is a drug that enhances the bone formation activity of osteoblasts rather than inhibiting bone reabsorption, making it different from the others listed.
Treatment and prevention strategies for osteoporosis often include bisphosphonates like Alendronate and Risedronate. Calcitonin additionally helps by preventing calcium movement from bone and encouraging phosphate deposition within bone. It's crucial to choose the appropriate therapy to manage bone health effectively, especially in conditions like osteoporosis and Paget's disease.